Clinical trial
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
NCT02223052
Study timeline
Study start (actual)2014-10-27Date precision: day
Registry last updated2020-05-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hematological Neoplasmsunresolved
Hodgkin's Lymphomaverified · MONDO: Hodgkins lymphoma
Lymphomaverified · MONDO: lymphoma
Multiple Myelomaunresolved
Leukemiaverified · MONDO: leukemia
Neoplasmsunresolved
Melanomaverified · MONDO: melanoma
Breast Cancerverified · MONDO: breast cancer
Metastatic Breast Cancerunresolved
Glioblastoma Multiformeverified · MONDO: glioblastoma
Osteosarcomaverified · MONDO: osteosarcoma
Sarcomaverified · MONDO: sarcoma
Thyroid Cancerverified · MONDO: thyroid cancer
Genitourinaryunresolved
Interventions
CC-486DRUG
VidazaDRUG · verified · RxNorm: Vidaza
Sponsors & collaborators
Celgenelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02223052 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.